INJECTION SITE ERYTHEMA

This adverse event was reported 88826 times

These drugs are most commonly taken by patients reporting INJECTION SITE ERYTHEMA:

# Drug Count
0 ETANERCEPT 40600
1 ADALIMUMAB 12690
2 METHOTREXATE SODIUM 5989
3 METHOTREXATE 5908
4 TERIPARATIDE 4818
5 INTERFERON BETA-1A 3689
6 FOLIC ACID 2470
7 PREDNISONE 2394
8 GLATIRAMER ACETATE 2065
9 ERGOCALCIFEROL 2024
See all common drugs associated with INJECTION SITE ERYTHEMA

INJECTION SITE ERYTHEMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE 13 0.4643
1 TUBERCULIN PURIFIED PROTEIN DERIVATIVE 234 0.1251
2 PEGVALIASE-PQPZ 352 0.1158
3 OMACETAXINE MEPESUCCINATE 64 0.0967
4 ASFOTASE ALFA 403 0.0866
5 PEGINTERFERON BETA-1A 833 0.0835
6 ETANERCEPT 40600 0.0763
7 DEGARELIX 214 0.0761
8 IXEKIZUMAB 1192 0.0730
9 FREMANEZUMAB-VFRM 242 0.0722
See all drugs enriched for association with INJECTION SITE ERYTHEMA

INJECTION SITE ERYTHEMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Skin Test Antigen [EPC] 234 0.1249
1 Phenylalanine Metabolizing Enzyme [EPC] 352 0.1158
2 Tissue-nonspecific Alkaline Phosphatase [EPC] 403 0.0866
3 Tumor Necrosis Factor Blocker [EPC] 41224 0.0550
4 Interleukin-1 Receptor Antagonist [EPC] 462 0.0492
5 Parathyroid Hormone Analog [EPC] 4818 0.0468
6 Cytolytic Agent [EPC] 55 0.0315
7 PCSK9 Inhibitor [EPC] 512 0.0296
8 Endoglycosidase [EPC] 28 0.0287
9 Interferon beta [EPC] 4501 0.0240
See all drug classes enriched for association with INJECTION SITE ERYTHEMA